Nicole Grant

2.6k total citations
37 papers, 1.8k citations indexed

About

Nicole Grant is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Nicole Grant has authored 37 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pathology and Forensic Medicine, 14 papers in Oncology and 10 papers in Genetics. Recurrent topics in Nicole Grant's work include Lymphoma Diagnosis and Treatment (27 papers), Chronic Lymphocytic Leukemia Research (9 papers) and CNS Lymphoma Diagnosis and Treatment (8 papers). Nicole Grant is often cited by papers focused on Lymphoma Diagnosis and Treatment (27 papers), Chronic Lymphocytic Leukemia Research (9 papers) and CNS Lymphoma Diagnosis and Treatment (8 papers). Nicole Grant collaborates with scholars based in United States, Australia and India. Nicole Grant's co-authors include Wyndham H. Wilson, Elaine S. Jaffe, Kieron Dunleavy, John E. Janik, Stefania Pittaluga, Seth M. Steinberg, Louis M. Staudt, Richard F. Little, Mark Raffeld and Margaret Shovlin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Nicole Grant

34 papers receiving 1.7k citations

Peers

Nicole Grant
N L Harris United States
R I Fisher United States
Gerald E. Byrne United States
DC Linch United Kingdom
Marc André Belgium
Nicole Grant
Citations per year, relative to Nicole Grant Nicole Grant (= 1×) peers Amalia De Renzo

Countries citing papers authored by Nicole Grant

Since Specialization
Citations

This map shows the geographic impact of Nicole Grant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole Grant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole Grant more than expected).

Fields of papers citing papers by Nicole Grant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole Grant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole Grant. The network helps show where Nicole Grant may publish in the future.

Co-authorship network of co-authors of Nicole Grant

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole Grant. A scholar is included among the top collaborators of Nicole Grant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole Grant. Nicole Grant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grant, Nicole & Natalie A. Phillips. (2023). Hearing loss is associated with decreased default-mode network connectivity in individuals with mild cognitive impairment. SHILAP Revista de lepidopterología. 3(4). 100188–100188.
2.
Grant, Nicole, et al.. (2020). The Effect of the Consent Process on Patient Satisfaction With Pain Management: A Randomized Controlled Trial. Annals of Emergency Medicine. 77(1). 82–90. 2 indexed citations
3.
Song, Joo Y., Stefania Pittaluga, Kieron Dunleavy, et al.. (2014). Lymphomatoid Granulomatosis—A Single Institute Experience. The American Journal of Surgical Pathology. 39(2). 141–156. 73 indexed citations
4.
Asha, Stephen, Kate Curtis, Nicole Grant, et al.. (2011). Comparison of radiation exposure of trauma patients from diagnostic radiology procedures before and after the introduction of a panscan protocol. Emergency Medicine Australasia. 24(1). 43–51. 57 indexed citations
5.
Marti, Gerald E., Maryalice Stetler‐Stevenson, Nicole Grant, et al.. (2011). Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate:in vivoevidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia. Leukemia & lymphoma. 52(12). 2284–2292. 19 indexed citations
6.
Dunleavy, Kieron, Richard F. Little, Stefania Pittaluga, et al.. (2010). The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma. Blood. 115(15). 3017–3024. 123 indexed citations
7.
Dunleavy, Kieron, Stefania Pittaluga, Myron S. Czuczman, et al.. (2009). Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. Blood. 113(24). 6069–6076. 371 indexed citations
8.
Grant, Nicole, et al.. (2009). Mesh erosion into the urinary bladder following laparoscopic inguinal hernia repair; is this the tip of the iceberg?. Hernia. 14(3). 317–319. 44 indexed citations
9.
Dunleavy, Kieron, Stefania Pittaluga, Kevin Tay, et al.. (2009). Comparative Clinical and Biological Features of Primary Mediastinal B-Cell Lymphoma (PMBL) and Mediastinal Grey Zone Lymphoma (MGZL).. Blood. 114(22). 106–106. 10 indexed citations
10.
Wilson, Wyndham H., Kieron Dunleavy, Stefania Pittaluga, et al.. (2008). Phase II Study of Dose-Adjusted EPOCH and Rituximab in Untreated Diffuse Large B-Cell Lymphoma With Analysis of Germinal Center and Post-Germinal Center Biomarkers. Journal of Clinical Oncology. 26(16). 2717–2724. 217 indexed citations
11.
Cole, Diane E., Frank M. Balis, Nicole Grant, et al.. (2008). Pharmacokinetics (pk) and tolerance of infusional vincristine (vcr) for aggressive lymphomas indicate dose reductions for excretory organ dysfunction are not necessary. Journal of Clinical Oncology. 26(15_suppl). 2550–2550. 1 indexed citations
12.
Dunleavy, Kieron, Stefania Pittaluga, Nicole Grant, et al.. (2008). Gray Zone Lymphomas: Clinical and Histological Characteristics and Treatment with Dose-Adjusted-EPOCH-R. Blood. 112(11). 3590–3590. 7 indexed citations
13.
Dunleavy, Kieron, Brian Bird, Stefania Pittaluga, et al.. (2007). Efficacy and toxicity of dose-adjusted EPOCH-rituximab in adults with newly diagnosed Burkitt lymphoma. Journal of Clinical Oncology. 25(18_suppl). 8035–8035. 6 indexed citations
14.
Patsalides, Athos, Gökçe Kaan Ataç, John E. Janik, et al.. (2005). Lymphomatoid Granulomatosis: Abnormalities of the Brain at MR Imaging. Radiology. 237(1). 265–273. 65 indexed citations
15.
Dunleavy, Kieron, Frances T. Hakim, Hyun Kyung Kim, et al.. (2005). B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis. Blood. 106(3). 795–802. 102 indexed citations
16.
Janik, John E., Kieron Dunleavy, Stefania Pittaluga, et al.. (2005). A Pilot Trial of Campath-1H and Dose-Adjusted EPOCH in CD52-Expressing Aggressive T-Cell Malignancies.. Blood. 106(11). 3348–3348. 12 indexed citations
17.
Dunleavy, Kieron, Stefania Pittaluga, John E. Janik, et al.. (2005). Primary Mediastinal Large B-Cell Lymphoma (PMBL) Outcome Is Significantly Improved by the Addition of Rituximab to Dose Adjusted (DA)-EPOCH and Overcomes the Need for Radiation.. Blood. 106(11). 929–929. 19 indexed citations
18.
Janik, John E., John C. Morris, Stefania Pittaluga, et al.. (2004). Elevated serum-soluble interleukin-2 receptor levels in patients with anaplastic large cell lymphoma. Blood. 104(10). 3355–3357. 39 indexed citations
19.
Wilson, Wyndham H., Kieron Dunleavy, Stefania Pittaluga, et al.. (2004). Dose-Adjusted EPOCH-Rituximab Is Highly Effective in the GCB and ABC Subtypes of Untreated Diffuse Large B-Cell Lymphoma.. Blood. 104(11). 159–159. 8 indexed citations
20.
Little, Richard F., Stefania Pittaluga, Nicole Grant, et al.. (2003). Highly effective treatment of acquired immunodeficiency syndrome–related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Blood. 101(12). 4653–4659. 234 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026